Basappa, N. S. “Treatment Options in Advanced Renal Cell Carcinoma After First-Line Treatment With Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors”. Canadian Urological Association Journal, vol. 10, no. 11-12, Dec. 2016, pp. S242-4, doi:10.5489/cuaj.4292.